Skip to main content

Granulomatous Disease clinical trials at UC Health
1 research study open to eligible people

  • Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995

    open to all eligible people

    Chronic granulomatous disease (CGD) is an inherited immune system abnormality in which bone marrow transplantation (BMT) has been shown to be curative. However the risks of transplantation are high and not all patients with CGD may need to undergo this high risk procedure. This study will determine the long term medical condition and daily functioning of participants with CGD after a transplant and if possible, compare these results to participants who do not undergo a transplant.

    at UCLA UCSF

Last updated: